Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.

Details

Serval ID
serval:BIB_FAD4AB8CFBBF
Type
Article: article from journal or magazin.
Collection
Publications
Title
Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.
Journal
European Heart Journal
Author(s)
Maury P., Baratto F., Zeppenfeld K., Klein G., Delacretaz E., Sacher F., Pruvot E., Brigadeau F., Rollin A., Andronache M., Maccabelli G., Gawrysiak M., Brenner R., Forclaz A., Schlaepfer J., Lacroix D., Duparc A., Mondoly P., Bouisset F., Delay M., Hocini M., Derval N., Sadoul N., Magnin-Poull I., Klug D., Haïssaguerre M., Jaïs P., Della Bella P., De Chillou C.
ISSN
1522-9645 (Electronic)
ISSN-L
0195-668X
Publication state
Published
Issued date
2014
Peer-reviewed
Oui
Volume
35
Number
22
Pages
1479-1485
Language
english
Notes
Publication types:
Publication Status: ppublish
Abstract
AIMS: Patients with well-tolerated sustained monomorphic ventricular tachycardia (SMVT) and left ventricular ejection fraction (LVEF) over 30% may benefit from a primary strategy of VT ablation without immediate need for a 'back-up' implantable cardioverter-defibrillator (ICD).
METHODS AND RESULTS: One hundred and sixty-six patients with structural heart disease (SHD), LVEF over 30%, and well-tolerated SMVT (no syncope) underwent primary radiofrequency ablation without ICD implantation at eight European centres. There were 139 men (84%) with mean age 62 ± 15 years and mean LVEF of 50 ± 10%. Fifty-five percent had ischaemic heart disease, 19% non-ischaemic cardiomyopathy, and 12% arrhythmogenic right ventricular cardiomyopathy. Three hundred seventy-eight similar patients were implanted with an ICD during the same period and serve as a control group. All-cause mortality was 12% (20 patients) over a mean follow-up of 32 ± 27 months. Eight patients (40%) died from non-cardiovascular causes, 8 (40%) died from non-arrhythmic cardiovascular causes, and 4 (20%) died suddenly (SD) (2.4% of the population). All-cause mortality in the control group was 12%. Twenty-seven patients (16%) had a non-fatal recurrence at a median time of 5 months, while 20 patients (12%) required an ICD, of whom 4 died (20%).
CONCLUSION: Patients with well-tolerated SMVT, SHD, and LVEF > 30% undergoing primary VT ablation without a back-up ICD had a very low rate of arrhythmic death and recurrences were generally non-fatal. These data would support a randomized clinical trial comparing this approach with others incorporating implantation of an ICD as a primary strategy.
Pubmed
Open Access
Yes
Create date
17/12/2014 14:35
Last modification date
23/01/2020 6:26
Usage data